Image
percipi224
As 5800 Canadian brain tumour patients raised a record 1.5 million for brain research in that country, GlaxoSmithKline and AstraZeneca are pulling research into a variety of brain disorders to include, tumours, depression, schizophrenia and most important due to the epidemic nature, alzheimers. This move is purported to be made due to the lucrative quality of cancer. The linked articles all discuss the monies involved.

"Cancer costs the economy half the amount of brain diseases but receives twice as much research money from European governments, said the ECNP."

Read more: http://www.dailymail.co.uk/health/article-2003434/Alzheimers-Sufferers-denied-ne...

ALSO: http://www.medicalnewstoday.com/articles/228512.php
AND:http://www.marketwire.com/press-release/record-breaking-funds-raised-brain-tumour-patients-across-canada-brain-tumour-foundation-1527946.htm
  1. groups:
  2. tags:
    Canada Drug companies brain research
  3.     
    |

0 comments // Brain Research Funding

top videos